
Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer’s dementia models
Keywords: Alzheimer’s diseases; M1 agonists; Morpholino arecolines; Displacement assay; Rat brain; In vitro; In vivo